Grant: Discovery Grants Program - Individual
McGill University
$69,000.00
Biomechanics of airway soft tissues for therapeutic treatments screening and delivery
FY 2024-25
Summary
The long-term objective of the proposed research program is to improve respiratory drug screening and local drug injection through the improved understanding of the physical and perfusion characteristics, the mechanical elasticity, and the fracture properties of airway soft tissues, in particular the vocal folds, the oral mucosa, and the lungs. The work plan is structured along three specific aims.
The first aim is to understand and model needle and needle-free injection of drugs through soft tissues, with a focus on the oral mucosa and skin for dental anesthesia. On average every individual receives 1.6 injection per year, 94% of which use a new needle. The use of needle-free injection could reduce material and environmental costs of discarded needles and could also be useful for the vaccination of people with a fear of needles, estimated to be around 10% of the population. The relative advantages and disadvantages of needle and needle-frees injections will be compared in terms of mechanical fracture, cell viability, and tissue inflammation in vitro using cell-seeded scaffold materials. Efforts will be made to create accurate computer models of injection that could be used to determine final drug concentrations and to quantify tissue damage and injury. A related aim is to create better soft tissue phantoms to test needle-free drug delivery in vitro. Currently available phantom materials fail to reproduce the fracture toughness of soft tissues.
The second aim is to quantify the role of elastin synthesis and osmolarity gradients on the viscoelasticity and injectability of the vocal fold lamina propria. The experimental approach involves the modulation of hydration through osmolarity gradients and that of elastin using polyphenols in cell-seeded constructs. Nonlinear laser scanning microscopy will be used to visualize and quantify the collagen and elastin distributions. A universal mechanical testing device and atomic force microscopy will be used to quantify viscoelastic properties. The encapsulation of polyphenol in injectable porous hydrogels could promote elastin synthesis, thereby restoring viscoelasticity and functionality to the vocal folds, the oral mucosa, or the skin. This could lead to improved therapeutics for sclerosis and aging.
The third aim is to create a physical model of lung tissues to provide a more realistic micro-environment for the growth of lung organoids for antiviral drug testing. A microfluidic system providing tidal breathing of air with carbon dioxide will be built. We will scale up the fabrication of our lower respiratory tract organoid to a deliverable system using bioprinting and cryopreservation. This work builds on recent progress in the creation of that recapitulate the mature and diverse structures and cellular populations of the lower respiratory tract involved in influenza H1N1 and SARS-CoV-2 infection. Cryopreserved organoids could help the Canadian pharmaceutical industry to speed up drug development.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2023-03833
Name nom
Mongeau, Luc
Department département
Mechanical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
69000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1903
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomechanics
Research subject fr
Biomécanique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Biomechanics of airway soft tissues for therapeutic treatments screening and delivery
Keywords
organoids; tissue engineering; high throughput drug screening; microfluidics; perfusion bioreactors; viscoelasticity; adhesion; fracture toughness; porous media; two-phase flows
Application summary
The long-term objective of the proposed research program is to improve respiratory drug screening and local drug injection through the improved understanding of the physical and perfusion characteristics, the mechanical elasticity, and the fracture properties of airway soft tissues, in particular the vocal folds, the oral mucosa, and the lungs. The work plan is structured along three specific aims.
The first aim is to understand and model needle and needle-free injection of drugs through soft tissues, with a focus on the oral mucosa and skin for dental anesthesia. On average every individual receives 1.6 injection per year, 94% of which use a new needle. The use of needle-free injection could reduce material and environmental costs of discarded needles and could also be useful for the vaccination of people with a fear of needles, estimated to be around 10% of the population. The relative advantages and disadvantages of needle and needle-frees injections will be compared in terms of mechanical fracture, cell viability, and tissue inflammation in vitro using cell-seeded scaffold materials. Efforts will be made to create accurate computer models of injection that could be used to determine final drug concentrations and to quantify tissue damage and injury. A related aim is to create better soft tissue phantoms to test needle-free drug delivery in vitro. Currently available phantom materials fail to reproduce the fracture toughness of soft tissues.
The second aim is to quantify the role of elastin synthesis and osmolarity gradients on the viscoelasticity and injectability of the vocal fold lamina propria. The experimental approach involves the modulation of hydration through osmolarity gradients and that of elastin using polyphenols in cell-seeded constructs. Nonlinear laser scanning microscopy will be used to visualize and quantify the collagen and elastin distributions. A universal mechanical testing device and atomic force microscopy will be used to quantify viscoelastic properties. The encapsulation of polyphenol in injectable porous hydrogels could promote elastin synthesis, thereby restoring viscoelasticity and functionality to the vocal folds, the oral mucosa, or the skin. This could lead to improved therapeutics for sclerosis and aging.
The third aim is to create a physical model of lung tissues to provide a more realistic micro-environment for the growth of lung organoids for antiviral drug testing. A microfluidic system providing tidal breathing of air with carbon dioxide will be built. We will scale up the fabrication of our lower respiratory tract organoid to a deliverable system using bioprinting and cryopreservation. This work builds on recent progress in the creation of that recapitulate the mature and diverse structures and cellular populations of the lower respiratory tract involved in influenza H1N1 and SARS-CoV-2 infection. Cryopreserved organoids could help the Canadian pharmaceutical industry to speed up drug development.